特朗普称已将药价下调1500%，美媒：这一“夸张说法”在数学上不可能

Core Viewpoint - President Trump claimed that the U.S. government has reduced prescription drug prices by up to 1500%, a statement that has been widely criticized by media outlets as mathematically impossible [1][3]. Group 1: Drug Pricing Claims - Trump stated that drug prices have been lowered by 1200%, 1300%, 1400%, and 1500%, emphasizing that these figures are not mere percentages like 50% [3]. - Media outlets pointed out that a 100% price reduction would mean drugs are free, while a reduction exceeding 100% implies that pharmaceutical companies would pay consumers to take the drugs [3]. Group 2: Government Response - White House spokesperson Kush DeSantis defended Trump's claims by stating that Americans pay significantly more for the same medications compared to other developed countries, asserting that the Trump administration has made substantial efforts to alleviate this burden [3]. - The statement reflects a misunderstanding of pricing and percentage operations, potentially undermining public confidence in Trump's ability to address drug pricing issues [3]. Group 3: Tariff Threats and Industry Impact - Trump has threatened to impose high tariffs on imported drugs, claiming this would lower drug prices and enhance national security [3]. - Industry professionals argue that achieving these goals is challenging due to complex supply chains and high domestic production costs, with tariff policies introducing further uncertainty for the U.S. pharmaceutical industry and companies [3].